The PDDF, in partnership with the Wistar Institute Center for Advanced Therapeutics, connects scientists from academia, biopharma, and government to advance drug discovery from target identification to clinical candidates. Our goal is to foster collaborations and regional partnerships to accelerate breakthroughs for patients and the global community.
Join us for our November 11 event featuring:
John D. Higgins, Ph.D.
Associate Professor of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania
“Oral Peptide Delivery and Highlights on Merck’s Enlicitide Success Story”
Christian Schafmeister, Ph.D.
Founder and President, ThirdLaw Molecular
“Building a New Drug Modality: Spiroligomers and our CD40L Lead Program”
Location:
The Wistar Institute
Caplan Auditorium
3601 Spruce St., Philadelphia, PA 19104
Special thanks to Rockland for supporting this event series!
